CPMC Research Institute Leads Study on Gene’s Role in Melanoma
May Result in Targeted Skin Cancer Treatment and Therapies
A study by the researchers at California Pacific Medical Center Research Institute (CPMCRI) was published in Proceedings of the National Academy of Sciences (PNAS). The findings reveal that increased expression of a gene in the deadly skin cancer melanoma can increase the risk of death from the tumor, and represents a possible new target for treatment of melanomas that express high levels of this gene.
“We’ve shown that this gene is a marker of increased risk of spread and of death due to melanoma,’’ said Mohammed Kashani-Sabet, MD, a dermatologist at Sutter Pacific Medical Foundation, Medical Director of the Center for Melanoma Research and Treatment at California Pacific Medical Center and the study’s senior author. “Studying this gene helps us to understand which melanomas are more aggressive. The hope is that further study will lead to targeted treatments for melanoma and other cancers.”